Literature DB >> 21964829

Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy?

Sheila Unger1, Ekkehart Lausch, Franco Stanzial, Gabriele Gillessen-Kaesbach, Irina Stefanova, Cristina Maria Di Stefano, Enrico Bertini, Carlo Dionisi-Vici, Bernd Nilius, Bernhard Zabel, Andrea Superti-Furga.   

Abstract

Dominant mutations in the receptor calcium channel gene TRPV4 have been associated with a family of skeletal dysplasias (metatropic dysplasia, pseudo-Morquio type 2, spondylometaphyseal dysplasia, Kozlowski type, brachyolmia, and familial digital arthropathy) as well as with dominantly inherited neuropathies (hereditary motor and sensory neuropathy 2C, scapuloperoneal spinal muscular atrophy, and congenital distal spinal muscular atrophy). While there is phenotypic overlap between the various members of each group, the two groups were considered to be totally separate with the former being strictly a structural skeletal condition and the latter group being confined to the peripheral nervous system. We report here on fetal akinesia as the presenting feature of severe metatropic dysplasia, suggesting that certain TRPV4 mutations can cause both a skeletal and a neuropathic phenotype. Three cases were detected on prenatal ultrasound because of absent movements in the second trimester. Case 4 presented with multiple joint contractures and absent limb movements at birth and was diagnosed with "fetal akinesia syndrome". Post-interruption and post-natal X-rays showed typical features of metatropic dysplasia in all four. Sequencing of the TRPV4 gene confirmed the presence of de novo heterozygous mutations predicting G78W (Case 1), T740I (Cases 2 and 3), and K276E (Case 4). Although some degree of restriction of movements is not uncommon in fetuses with skeletal dysplasia, akinesia as leading sign is unusual and suggests that certain TRPV4 mutations produce both chondrodysplasia and a peripheral neuropathy resulting in a severe "overlap" phenotype.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964829     DOI: 10.1002/ajmg.a.34268

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant.

Authors:  Eden Faye; Peggy Modaff; Richard Pauli; Janet Legare
Journal:  Mol Syndromol       Date:  2018-12-21

Review 2.  The puzzle of TRPV4 channelopathies.

Authors:  Bernd Nilius; Thomas Voets
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

3.  TRPV4 mutations in children with congenital distal spinal muscular atrophy.

Authors:  Chiara Fiorillo; Francesca Moro; Giacomo Brisca; Guja Astrea; Claudia Nesti; Zoltán Bálint; Andrea Olschewski; Maria Chiara Meschini; Christian Guelly; Michaela Auer-Grumbach; Roberta Battini; Marina Pedemonte; Alessandro Romano; Valeria Menchise; Roberta Biancheri; Filippo M Santorelli; Claudio Bruno
Journal:  Neurogenetics       Date:  2012-04-25       Impact factor: 2.660

Review 4.  Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation.

Authors:  Sang Sun Kang; Sung Hwa Shin; Chung-Kyoon Auh; Jaesun Chun
Journal:  Exp Mol Med       Date:  2012-12-31       Impact factor: 8.718

5.  Phenotypic variability of TRPV4 related neuropathies.

Authors:  Teresinha Evangelista; Boglarka Bansagi; Angela Pyle; Helen Griffin; Konstantinos Douroudis; Tuomo Polvikoski; Thalia Antoniadi; Kate Bushby; Volker Straub; Patrick F Chinnery; Hanns Lochmüller; Rita Horvath
Journal:  Neuromuscul Disord       Date:  2015-03-18       Impact factor: 4.296

6.  X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1.

Authors:  Noriko Miyake; Nicole I Wolf; Ferdy K Cayami; Joanna Crawford; Annette Bley; Dorothy Bulas; Alex Conant; Stephen J Bent; Karen W Gripp; Andreas Hahn; Sean Humphray; Shihoko Kimura-Ohba; Zoya Kingsbury; Bryan R Lajoie; Dennis Lal; Dimitra Micha; Amy Pizzino; Richard J Sinke; Deborah Sival; Irene Stolte-Dijkstra; Andrea Superti-Furga; Nicole Ulrick; Ryan J Taft; Tsutomu Ogata; Keiichi Ozono; Naomichi Matsumoto; Bernd A Neubauer; Cas Simons; Adeline Vanderver
Journal:  Neurogenetics       Date:  2017-08-26       Impact factor: 2.660

7.  Novel TRPV4 variant causes a severe form of metatropic dysplasia.

Authors:  Lise Graversen; Annette Haagerup; Brian N Andersen; Karin K Petersen; Vibike Gjørup; Gudrun Gudmundsdottir; Ida Vogel; Pernille A Gregersen
Journal:  Clin Case Rep       Date:  2018-07-20

Review 8.  TRPing to the Point of Clarity: Understanding the Function of the Complex TRPV4 Ion Channel.

Authors:  Trine L Toft-Bertelsen; Nanna MacAulay
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

9.  Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy.

Authors:  Jeremy M Sullivan; Christina M Zimanyi; William Aisenberg; Breanne Bears; Dong-Hui Chen; John W Day; Thomas D Bird; Carly E Siskind; Rachelle Gaudet; Charlotte J Sumner
Journal:  Neurol Genet       Date:  2015-10-22

10.  De novo TRPV4 Leu619Pro variant causes a new channelopathy characterised by giant cell lesions of the jaws and skull, skeletal abnormalities and polyneuropathy.

Authors:  Aviel Ragamin; Carolina C Gomes; Nada Jabado; Grazia Maria Simonetta Mancini; Ricardo Santiago Gomez; Karen Bindels-de Heus; Renata Sandoval; Angelia V Bassenden; Luciano Dib; Fernando Kok; Julieta Alves; Irene Mathijssen; Evita Medici-Van den Herik; Robert Eveleigh; Tenzin Gayden; Bas Pullens; Albert Berghuis; Marjon van Slegtenhorst; Martina Wilke
Journal:  J Med Genet       Date:  2021-03-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.